Last updated: 18 July 2019 at 8:25pm EST

Andre Walker Net Worth




The estimated Net Worth of Andre Walker is at least $32.8 Thousand dollars as of 8 June 2016. Andre Walker owns over 6,000 units of Nevro Corp stock worth over $32,786 and over the last 10 years Andre sold NVRO stock worth over $0.

Andre Walker NVRO stock SEC Form 4 insiders trading

Andre has made over 13 trades of the Nevro Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently Andre exercised 6,000 units of NVRO stock worth $8,640 on 8 June 2016.

The largest trade Andre's ever made was exercising 8,000 units of Nevro Corp stock on 30 November 2015 worth over $7,680. On average, Andre trades about 3,401 units every 19 days since 2014. As of 8 June 2016 Andre still owns at least 6,961 units of Nevro Corp stock.

You can see the complete history of Andre Walker stock trades at the bottom of the page.



What's Andre Walker's mailing address?

Andre's mailing address filed with the SEC is C/O NEVRO CORP., 4040 CAMPBELL AVENUE, MENLO PARK, CA, 94025.

Insiders trading at Nevro Corp

Over the last 10 years, insiders at Nevro Corp have traded over $298,472,982 worth of Nevro Corp stock and bought 312,708 units worth $8,709,518 . The most active insiders traders include Ali Behbahani, Holdings A/S Novo, and & Johnson Johnson & Johnson.... On average, Nevro Corp executives and independent directors trade stock every 18 days with the average trade being worth of $161,002. The most recent stock trade was executed by Shawn Mc Cormick on 7 June 2023, trading 7,500 units of NVRO stock currently worth $171,600.



What does Nevro Corp do?

headquartered in redwood city, california, nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. nevro has developed and commercialized the senza spinal cord stimulation (scs) system, an evidence-based neuromodulation platform for the treatment of chronic pain. the senza system is the only scs system that delivers nevro's proprietary hf10 therapy. the nevro® senza® scs system received ce mark in 2010, tga approval in 2011, fda approval in 2015, and is commercially available in europe, australia, and the united states.



Complete history of Andre Walker stock trades at Nevro Corp

Insider
Trans.
Transaction
Total value
Andre Walker
Senior VP, Research, and Development
Option $8,640
8 Jun 2016
Andre Walker
Senior VP, Research, and Development
Option $8,640
8 Jun 2016
Andre Walker
Senior VP, Research, and Development
Option $5,760
1 Jun 2016
Andre Walker
Senior VP, Research, and Development
Option $5,760
1 Jun 2016
Andre Walker
Senior VP, Research, and Development
Option $11,501
11 Jan 2016
Andre Walker
Senior VP, Research, and Development
Option $19
17 Dec 2015
Andre Walker
Senior VP, Research, and Development
Option $4,320
14 Dec 2015
Andre Walker
Senior VP, Research, and Development
Option $2,034
10 Dec 2015
Andre Walker
Senior VP, Research, and Development
Option $960
2 Dec 2015
Andre Walker
Senior VP, Research, and Development
Option $7,680
30 Nov 2015
Andre Walker
Senior VP, Research, and Development
Option $960
24 Nov 2015
Andre Walker
Senior VP, Research, and Development
Option $960
23 Nov 2015
Andre Walker
Senior VP, Research, and Development
Option $3,840
17 Sep 2015


Nevro Corp executives and stock owners

Nevro Corp executives and other stock owners filed with the SEC include: